A Chimera of Th1 Stimulatory Proteins of Leishmania donovani Offers Moderate Immunotherapeutic Efficacy with a Th1-Inclined Immune Response against Visceral Leishmaniasis.

MLA

Ratnapriya, Sneha, et al. “A Chimera of Th1 Stimulatory Proteins of Leishmania Donovani Offers Moderate Immunotherapeutic Efficacy with a Th1-Inclined Immune Response against Visceral Leishmaniasis.” BioMed Research International, Apr. 2021, pp. 1–14. EBSCOhost, https://doi.org/10.1155/2021/8845826.

APA

Ratnapriya, S., Keerti, Yadav, N. K., Dube, A., & Sahasrabuddhe, A. A. (2021). A Chimera of Th1 Stimulatory Proteins of Leishmania donovani Offers Moderate Immunotherapeutic Efficacy with a Th1-Inclined Immune Response against Visceral Leishmaniasis. BioMed Research International, 1–14. https://doi.org/10.1155/2021/8845826

Chicago

Ratnapriya, Sneha, Keerti, Narendra Kumar Yadav, Anuradha Dube, and Amogh Anant Sahasrabuddhe. 2021. “A Chimera of Th1 Stimulatory Proteins of Leishmania Donovani Offers Moderate Immunotherapeutic Efficacy with a Th1-Inclined Immune Response against Visceral Leishmaniasis.” BioMed Research International, April, 1–14. doi:10.1155/2021/8845826.